Insulin-like growth factors and their carrier proteins in kidneys of rats with experimental diabetes, malignant tumor, and their combination
暂无分享,去创建一个
E. Frantsiyants | V. Bandovkina | I. Kaplieva | I. Neskubina | E. Surikova | N. Cheryarina | M. Morozova | I. Kotieva | L. Trepitaki | Y. Pogorelova
[1] Ziyan Wang,et al. Acute Hyperglycemia May Induce Renal Tubular Injury Through Mitophagy Inhibition , 2020, Frontiers in Endocrinology.
[2] S. K. Pal,et al. Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement , 2020, Diabetes Therapy.
[3] Mina Wang,et al. Diabetes and cancer: Epidemiological and biological links , 2020, World journal of diabetes.
[4] T. P. Protasova,et al. О РАСШИРЕНИИ ВАРИАНТОВ ИСПОЛЬЗОВАНИЯ МЫШЕЙ BALB/C NUDE ДЛЯ ЭКСПЕРИМЕНТАЛЬНОГО ИЗУЧЕНИЯ ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ ЧЕЛОВЕКА IN VIVO , 2020 .
[5] Xiaolei Tang,et al. IGF-1 Deficiency Rescue and Intracellular Calcium Blockade Improves Survival and Corresponding Mechanisms in a Mouse Model of Acute Kidney Injury , 2020, International journal of molecular sciences.
[6] Xiao-ming Meng,et al. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression , 2020, Signal Transduction and Targeted Therapy.
[7] Yusuke Suzuki,et al. Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease , 2019, Journal of diabetes investigation.
[8] A. Czarnecka,et al. Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators , 2019, Journal of Cell Communication and Signaling.
[9] S. Rosen,et al. Why Have Detection, Understanding and Management of Kidney Hypoxic Injury Lagged behind Those for the Heart? , 2019, Journal of clinical medicine.
[10] R. Faragher,et al. Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing , 2018, Biogerontology.
[11] Javier Díez Espino,et al. Chronic renal disease in Spain: Prevalence and related factors in persons with diabetes mellitus older than 64 years , 2018, Nefrología (English Edition).
[12] C. Ronco,et al. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption , 2017, Clinical chemistry and laboratory medicine.
[13] K. Budde,et al. Biomarkers in acute kidney injury – pathophysiological basis and clinical performance , 2017, Acta physiologica.
[14] A. Levin,et al. Chronic kidney disease , 2017, Nature Reviews Disease Primers.
[15] Zengbin Wu,et al. IGF-1 protects tubular epithelial cells during injury via activation of ERK/MAPK signaling pathway , 2016, Scientific Reports.
[16] M. Prostran,et al. Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations. , 2016, Current medicinal chemistry.
[17] E. Hanse,et al. Erratum: Structural Mechanism for Regulation of Bcl-2 protein Noxa by phosphorylation , 2015, Scientific Reports.
[18] Елена Михайловна Франциянц,et al. Роль маркеров острого повреждения почек в выборе тактики хирургического лечения больных раком почки , 2015 .
[19] Y. Shibagaki,et al. Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia , 2015, PloS one.
[20] L. Bach,et al. Insulin-like growth factors and kidney disease. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] L. Chawla,et al. Biomarkers of renal function, which and when? , 2015, Clinica chimica acta; international journal of clinical chemistry.